INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults
INOVIO is leveraging a cutting-edge platform to advance DNA medicine candidates with the potential to transform disease prevention and treatment paradigms and improve patients’ lives.
© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.
